Nestle eyes products for weight-loss drug users

Swiss food giant Nestle is capitalizing on the growing popularity of GLP-1 weight loss drugs by seeking to transform this trend into a commercial opportunity. Utilizing artificial intelligence and nutritional expertise, the company aims to develop products to cater to the millions of consumers who rely on medications like Ozempic and Wegovy.

The rapid adoption of these drugs has raised concerns among investors about the potential long-term impact on demand for packaged foods, snacks, and beverages. Nestle believes that the drugs are also creating a new market for products addressing the side effects of rapid weight loss.

Chief Technology Officer Stefan Palzer explained that Nestle is leveraging AI and advanced technology to analyze clinical research, pinpoint nutrient combinations, and create tailored products for GLP-1 users. The company is well-positioned with its existing product portfolio, and Palzer expressed optimism about the tremendous business opportunity presented by this trend.

Clinical studies have shown that rapid weight loss can lead to side effects such as muscle loss and facial fat loss, commonly referred to as the "Ozempic face." Nestle has identified key areas where its products can help alleviate these issues. The company is utilizing AI to process vast amounts of clinical research, identify nutrient combinations that may support muscle health, hydration, and overall nutritional intake, and develop products accordingly.

Nestle's scientists are investigating methods to address lean muscle mass loss associated with weight loss, including developing a proprietary combination of micronutrients that stimulate muscle tissue growth. The company has also patented specific ingredient combinations designed to reduce appetite among consumers who experience increased hunger after discontinuing GLP-1 treatments.

Nestle has already launched products targeting GLP-1 users, such as Boost Advanced Nutrition Shake in the U.S. and a higher-protein Milo PRO High Protein version in Asia and Australia.

Artificial intelligence plays a significant role in Nestle's product development process. The company has created internal systems to analyze scientific literature, simulate consumer behavior, identify emerging trends, and help product developers navigate an extensive database of around 120,000 recipes. Additionally, Nestle is testing AI-driven consumer simulations to predict how shoppers will respond to new products and health claims before they reach the shelves.

AI is also being employed to monitor social media and identify emerging consumer trends, allowing Nestle to determine whether a topic represents a lasting trend or not.